Testicular anti-müllerian hormone: Clinical applications in DSD

Seminars in Reproductive Medicine

Volumn 30, Issue 5, 2012, Pages 364-373

  Josso, Nathalie ^a   Rey, Rodolfo ^b,c   Picard, Jean Yves ^a  

^a INSERM   (France)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

ambiguous genitalia; steroidogenesis; testis differentiation

Indexed keywords

ANDROGEN; MUELLERIAN INHIBITING FACTOR; TESTIS PEPTIDE HORMONE;

ARTICLE; CELL FUNCTION; CELL SPECIFICITY; CLINICAL FEATURE; GENE MUTATION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOGONADISM; LEYDIG CELL; MALE GENITAL SYSTEM; MOLECULAR GENETICS; MORPHOGENESIS; MUELLERIAN DUCT; ONTOGENY; SERTOLI CELL; SEX DIFFERENTIATION DISORDER; TESTIS; UTERINE TUBE; UTERUS;

ANIMALS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; DISORDERS OF SEX DEVELOPMENT; FETAL DEVELOPMENT; HUMANS; LEYDIG CELLS; MALE; MUTATION; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SERTOLI CELLS; TESTIS; TESTOSTERONE;

EID: 84867013302     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0032-1324719     Document Type: Article

References (94)

1. Racine C., Rey R., Forest M. G., et al. Receptors for anti-müllerian hormone on Leydig cells are responsible for its effects on steroidogenesis and cell differentiation. Proc Natl Acad Sci U S A: 1998; 95 2 594 599
2. Durlinger A. L., Visser J. A., Themmen A. P. Regulation of ovarian function: the role of anti-Müllerian hormone. Reproduction: 2002; 124 5 601 609
3. Bergadá I., Milani C., Bedecarrás P., et al. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life. J Clin Endocrinol Metab: 2006; 91 10 4092 4098
4. Guibourdenche J., Lucidarme N., Chevenne D., et al. Anti-Müllerian hormone levels in serum from human foetuses and children: pattern and clinical interest. Mol Cell Endocrinol: 2003; 211 1-2 55 63
5. Aksglaede L., Sorensen K., Boas M., et al. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab: 2010; 95 12 5357 5364
6. Grinspon R. P., Bedecarrás P., Ballerini M. G., et al. LAREP Group Early onset of primary hypogonadism revealed by serum anti-Müllerian hormone determination during infancy and childhood in trisomy 21. Int J Androl: 2011; 34 5 Pt 2 e487 e498
7. Nelson S. M., Messow M. C., McConnachie A., et al. External validation of nomogram for the decline in serum anti-Müllerian hormone in women: a population study of 15,834 infertility patients. Reprod Biomed Online: 2011; 23 2 204 206
8. Nelson S. M., La Marca A. The journey from the old to the new AMH assay: how to avoid getting lost in the values. Reprod Biomed Online: 2011; 23 4 411 420
9. Cate R. L., Mattaliano R. J., Hession C., et al. Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells. Cell: 1986; 45 5 685 698
10. Pepinsky R. B., Sinclair L. K., Chow E. P., et al. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J Biol Chem: 1988; 263 35 18961 18964
11. di Clemente N., Jamin S. P., Lugovskoy A., et al. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-β Mol Endocrinol: 2010; 24 11 2193 2206
12. Vigier B., Picard J. Y., Tran D., Legeai L., Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology: 1984; 114 4 1315 1320
13. Rey R., Sabourin J. C., Venara M., et al. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol: 2000; 31 10 1202 1208
14. Visser J. A., de Jong F. H., Laven J. SE, Themmen A. PN. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction: 2006; 131 1 1 9
15. De Santa Barbara P., Bonneaud N., Boizet B., et al. Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Müllerian hormone gene. Mol Cell Biol: 1998; 18 11 6653 6665
16. Arango N. A., Lovell-Badge R., Behringer R. R. Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development. Cell: 1999; 99 4 409 419
17. Shen W. H., Moore C. C., Ikeda Y., Parker K. L., Ingraham H. A. Nuclear receptor steroidogenic factor 1 regulates the müllerian inhibiting substance gene: a link to the sex determination cascade. Cell: 1994; 77 5 651 661
18. Watanabe K., Clarke T. R., Lane A. H., Wang X., Donahoe P. K. Endogenous expression of Müllerian inhibiting substance in early postnatal rat sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites. Proc Natl Acad Sci U S A: 2000; 97 4 1624 1629
19. Viger R. S., Mertineit C., Trasler J. M., Nemer M. Transcription factor GATA-4 is expressed in a sexually dimorphic pattern during mouse gonadal development and is a potent activator of the Müllerian inhibiting substance promoter. Development: 1998; 125 14 2665 2675
20. Hossain A., Saunders G. F. Role of Wilms tumor 1 (WT1) in the transcriptional regulation of the Mullerian-inhibiting substance promoter. Biol Reprod: 2003; 69 6 1808 1814
21. Lukas-Croisier C., Lasala C., Nicaud J., et al. Follicle-stimulating hormone increases testicular Anti-Mullerian hormone (AMH) production through sertoli cell proliferation and a nonclassical cyclic adenosine 5-monophosphate-mediated activation of the AMH Gene. Mol Endocrinol: 2003; 17 4 550 561
22. Rey R. A., Venara M., Coutant R., et al. Unexpected mosaicism of R201H-GNAS1 mutant-bearing cells in the testes underlie macro-orchidism without sexual precocity in McCune-Albright syndrome. Hum Mol Genet: 2006; 15 24 3538 3543
23. Lasala C., Schteingart H. F., Arouche N., et al. SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1. Am J Physiol Endocrinol Metab: 2011; 301 3 E539 E547
24. Rey R., Lordereau-Richard I., Carel J. C., et al. Anti-müllerian hormone and testosterone serum levels are inversely during normal and precocious pubertal development. J Clin Endocrinol Metab: 1993; 77 5 1220 1226
25. Al-Attar L., Noël K., Dutertre M., et al. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest: 1997; 100 6 1335 1343
26. Grinspon R. P., Rey R. A. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism. Horm Res Paediatr: 2010; 73 2 81 92
27. Berensztein E. B., Baquedano M. S., Gonzalez C. R., et al. Expression of aromatase, estrogen receptor alpha and beta, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis. Pediatr Res: 2006; 60 6 740 744
28. Chemes H. E., Rey R. A., Nistal M., et al. Physiological androgen insensitivity of the fetal, neonatal, and early infantile testis is explained by the ontogeny of the androgen receptor expression in Sertoli cells. J Clin Endocrinol Metab: 2008; 93 11 4408 4412
29. Boukari K., Meduri G., Brailly-Tabard S., et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J Clin Endocrinol Metab: 2009; 94 5 1818 1825
30. Rey R. A., Codner E., Iñíguez G., et al. Low risk of impaired testicular Sertoli and Leydig cell functions in boys with isolated hypospadias. J Clin Endocrinol Metab: 2005; 90 11 6035 6040
31. Feyaerts A., Forest M. G., Morel Y., et al. Endocrine screening in 32 consecutive patients with hypospadias. J Urol: 2002; 168 2 720 725, discussion 725
32. Josso N. Paediatric applications of anti-müllerian hormone research. 1992 Andrea Prader Lecture. Horm Res: 1995; 43 6 243 248
33. Lee M. M., Donahoe P. K., Silverman B. L., et al. Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. N Engl J Med: 1997; 336 21 1480 1486
34. Rey R. A., Belville C., Nihoul-Fékété C., et al. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab: 1999; 84 2 627 631
35. Morel Y., Rey R., Teinturier C., et al. Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr: 2002; 161 1 49 59
36. Plotton I., Gay C. L., Bertrand A. M., et al. AMH determination is essential for the management of 46,XY DSD patients. Pediatr Res: 2009; 72 suppl. 3 365
37. Hagen C. P., Aksglaede L., Sorensen K., et al. Serum levels of anti-Müllerian hormone as a marker of ovarian function in 926 healthy females from birth to adulthood and in 172 Turner syndrome patients. J Clin Endocrinol Metab: 2010; 95 11 5003 5010
38. Adamsbaum C., Rolland Y., Josso N., Kalifa G. Radiological findings in three cases of persistent müllerian duct syndrome. Pediatr Radiol: 1993; 23 1 55 56
39. Gutte A. A., Pendharkar P. S., Sorte S. Z. Transverse testicular ectopia associated with persistent Mullerian duct syndrome - the role of imaging. Br J Radiol: 2008; 81 967 e176 e178
40. El-Gohary M. A. Laparoscopic management of persistent müllerian duct syndrome. Pediatr Surg Int: 2003; 19 7 533 536
41. Lang-Muritano M., Biason-Lauber A., Gitzelmann C., Belville C., Picard Y., Schoenle E. J. A novel mutation in the anti-müllerian hormone gene as cause of persistent müllerian duct syndrome. Eur J Pediatr: 2001; 160 11 652 654
42. Asthana S., Deo S. V., Shukla N. K., Raina V., Kumar L. Persistent Mullerian duct syndrome presenting with bilateral intra-abdominal gonadal tumours and obstructive uropathy. Clin Oncol (R Coll Radiol): 2001; 13 4 304 306
43. Berkmen F. Persistent müllerian duct syndrome with or without transverse testicular ectopia and testis tumours. Br J Urol: 1997; 79 1 122 126
44. Bucci S., Liguori G., Buttazzi L., Bussani R., Trombetta C. Bilateral testicular carcinoma in patient with the persistent müllerian duct syndrome. J Urol: 2002; 167 4 1790
45. Prakash N., Khurana A., Narula B. Persistent Müllerian duct syndrome. Indian J Pathol Microbiol: 2009; 52 4 546 548
46. Chiang C. Y., Tsai J. W., Wang H. P., Sung Y. Z., Chang L. C. Hernia uterine inguinale and seminoma in persistent Müllerian duct syndrome. Int J Surg Pathol: 2010; 18 5 440 442
47. Shinmura Y., Yokoi T., Tsutsui Y. A case of clear cell adenocarcinoma of the müllerian duct in persistent müllerian duct syndrome: the first reported case. Am J Surg Pathol: 2002; 26 9 1231 1234
48. Dekker H. M., de Jong I. J., Sanders J., Wolf R. F. Persistent Müllerian duct syndrome. Radiographics: 2003; 23 2 309 313
49. Romero F. R., Fucs M., Castro M. G., Garcia C. R., Fernandes RdeC, Perez M. D. Adenocarcinoma of persistent müllerian duct remnants: case report and differential diagnosis. Urology: 2005; 66 1 194 195
50. Gricourt S., Treton D., Renard-Pennat R., et al. Novel anti-mullerian hormone mutation revealed by haematospermia in a 60-year-old patient. Clin Endocrinol (Oxf): 2011; 74 3 404 405
51. Martin E. L., Bennett A. H., Cromie W. J. Persistent müllerian duct syndrome with transverse testicular ectopia and spermatogenesis. J Urol: 1992; 147 6 1615 1617
52. Miller A., Hong M. K., Hutson J. M. The broad ligament: a review of its anatomy and development in different species and hormonal environments. Clin Anat: 2004; 17 3 244 251
53. Naouar S., Maazoun K., Sahnoun L., et al. Transverse testicular ectopia: a three-case report and review of the literature. Urology: 2008; 71 6 1070 1073
54. Abduljabbar M. A., Taheini K., Picard J. Y., Cate R. L., Josso N. Mutations of the AMH type II receptor in two extended families with persistent Müllerian duct syndrome: lack of phenotype/genotype correlation. Horm Res Paediatr: 2012; 77 5 291 297
55. Chaabane W., Jarboui L., Sahnoun A., et al. Persistent Müllerian duct syndrome with torsion of a transverse testicular ectopia: first reported case. Urology: 2010; 76 1 65 66
56. Imbeaud S., Rey R., Berta P., et al. Testicular degeneration in three patients with the persistent müllerian duct syndrome. Eur J Pediatr: 1995; 154 3 187 190
57. Josso N., Fékété C. N., Cachin O., Nezelof C., Rappaport R. Persistence of Müllerian ducts in male pseudohermaphroditism, and its relationship to cryptorchidism. Clin Endocrinol (Oxf): 1983; 19 2 247 258
58. Farag T. I. Familial persistent müllerian duct syndrome in Kuwait and neighboring populations. Am J Med Genet: 1993; 47 3 432 434
59. Vandersteen D. R., Chaumeton A. K., Ireland K., Tank E. S. Surgical management of persistent müllerian duct syndrome. Urology: 1997; 49 6 941 945
60. Lindgren B. W., Franco I., Blick S., et al. Laparoscopic Fowler-Stephens orchiopexy for the high abdominal testis. J Urol: 1999; 162 3 Pt 2 990 993, discussion 994
61. Brandli D. W., Akbal C., Eugsster E., Hadad N., Havlik R. J., Kaefer M. Persistent Mullerian duct syndrome with bilateral abdominal testis: surgical approach and review of the literature. J Pediatr Urol: 2005; 1 6 423 427
62. Josso N., Belville C., di Clemente N., Picard J. Y. AMH and AMH receptor defects in persistent Müllerian duct syndrome. Hum Reprod Update: 2005; 11 4 351 356
63. Belville C., Van Vlijmen H., Ehrenfels C., et al. Mutations of the anti-mullerian hormone gene in patients with persistent mullerian duct syndrome: biosynthesis, secretion, and processing of the abnormal proteins and analysis using a three-dimensional model. Mol Endocrinol: 2004; 18 3 708 721
64. Cohen-Haguenauer O., Picard J. Y., Mattéi M. G., et al. Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19. Cytogenet Cell Genet: 1987; 44 1 2 6
65. Sloan W. R., Walsh P. C. Familial persistent Müllerian duct syndrome. J Urol: 1976; 115 4 459 461
66. Naguib K. K., Teebi A. S., Farag T. I., al-Awadi S. A., el-Khalifa M. Y., el-Sayed Mahfouz. Familial uterine hernia syndrome: report of an Arab family with four affected males. Am J Med Genet: 1989; 33 2 180 181
67. Knebelmann B., Boussin L., Guerrier D., et al. Anti-Müllerian hormone Bruxelles: a nonsense mutation associated with the persistent Müllerian duct syndrome. Proc Natl Acad Sci U S A: 1991; 88 9 3767 3771
68. Mazen I., Abdel Hamid M. S., El-Gammal M., Aref A., Amr K. AMH gene mutations in two Egyptian families with persistent müllerian duct syndrome. Sex Dev: 2011; 5 6 277 280
69. Menabò S., Balsamo A., Nicoletti A., et al. Three novel AMH gene mutations in a patient with persistent mullerian duct syndrome and normal AMH serum dosage. Horm Res: 2008; 70 2 124 128
70. Nishio R., Fuse H., Akashi T., Furuya Y. Persistent Müllerian duct syndrome: a surgical approach. Arch Androl: 2003; 49 6 479 482
71. Takahashi C., Fujito A., Kazuka M., Sugiyama R., Ito H., Isaka K. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril: 2008; 89 3 586 591
72. Wu H. C., Chen J. H., Lu H. F., Shen W. C. Persistent müllerian duct syndrome wtih seminoma: CT findings. AJR Am J Roentgenol: 2000; 174 1 102 104
73. Gökce M. I., Burgu B., Aydodu O., Fitöz S., Soygür T. Transverse testicular ectopia associated with persistent Müllerian duct syndrome: another entity in which magnetic resonance imaging is unreliable. Urology: 2010; 76 6 1475 1477
74. Odi T. O., Abdur-Rahman L. O., Nasir A. A. Persistent Mullerian duct syndrome: a case report and review of the literature. Afr J Paediatr Surg: 2010; 7 3 191 193
75. Macedo A. Jr, Barroso U. Jr, Ottoni S. L., Ortiz V. Transverse testicular ectopia and persistent Müllerian duct syndrome. J Pediatr Urol: 2009; 5 3 234 236
76. Wuerstle M., Lesser T., Hurwitz R., Applebaum H., Lee S. L. Persistent mullerian duct syndrome and transverse testicular ectopia: embryology, presentation, and management. J Pediatr Surg: 2007; 42 12 2116 2119
77. Costa E., Domenice S., Sireilli M., Inacio M., Mendonca B. DSD due to 5α-reductase 2 deficiencyfrom diagnosis to long-term outcome. Semin Reprod Med: 2012; 30 5 427 431
78. Stuchi-Perez E. G., Hackel C., Oliveira L. E., et al. Diagnosis of 5alpha-reductase type 2 deficiency: contribution of anti-Müllerian hormone evaluation. J Pediatr Endocrinol Metab: 2005; 18 12 1383 1389
79. Hughes I., Werner R., Bunch T., Hiort O. Androgen insensitivity syndrome. Semin Reprod Med: 2012; 30 5 432 442
80. Bouvattier C., Carel J. C., Lecointre C., et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab: 2002; 87 1 29 32
81. Rey R., Mebarki F., Forest M. G., et al. Anti-müllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab: 1994; 79 4 960 964
82. Baarends W. M., van Helmond M. J., Post M., et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the müllerian duct. Development: 1994; 120 1 189 197
83. di Clemente N., Wilson C., Faure E., et al. Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol: 1994; 8 8 1006 1020
84. Jamin S. P., Arango N. A., Mishina Y., Hanks M. C., Behringer R. R. Requirement of Bmpr1a for Müllerian duct regression during male sexual development. Nat Genet: 2002; 32 3 408 410
85. Imbeaud S., Faure E., Lamarre I., et al. Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor. Nat Genet: 1995; 11 4 382 388
86. Hoshiya M., Christian B. P., Cromie W. J., et al. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene. Birth Defects Res A Clin Mol Teratol: 2003; 67 10 868 874
87. Klosowski S., Abriak A., Morisot C., et al. [Jejunal atresia and persistent mullerian duct syndrome]. Arch Pediatr: 1997; 4 12 1264 1265
88. Josso N., Clemente N. Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol Metab: 2003; 14 2 91 97
89. Kobayashi A., Stewart C. A., Wang Y., et al. β-Catenin is essential for Müllerian duct regression during male sexual differentiation. Development: 2011; 138 10 1967 1975
90. Tanwar P. S., Zhang L., Tanaka Y., Taketo M. M., Donahoe P. K., Teixeira J. M. Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme. Proc Natl Acad Sci U S A: 2010; 107 37 16142 16147
91. Bellini C., Bonioli E., Josso N., et al. Persistence of Müllerian derivatives and intestinal lymphangiectasis in two newborn brothers: confirmation of the Urioste syndrome. Am J Med Genet: 2001; 104 1 69 74
92. Van Maldergem L., Bachy A., Feldman D., et al. Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Müllerian ducts in a Turkish boy born to consanguineous parents. Am J Med Genet: 1996; 64 3 506 513
93. Bashamboo A., Ledig S., Wieacker P., Achermann J. C., McElreavey K. New technologies for the identification of novel genetic markers of disorders of sex development (DSD). Sex Dev: 2010; 4 45 213 224
94. Hughes I. A., Houk C., Ahmed S. F., Lee P. A.; LWPES Consensus Group; ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child: 2006; 91 7 554 563.